DYSS SRL
8.3 FTEThe score of DYSS shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +79 % Total assets +28 % Headcount (avg FTE) +30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DYSS's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
DYSS's financial analysis
- Solvency27.7%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DYSS
DYSS's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0635.840.641
- VAT number
- BE0635840641
- Peppol
- Registered · 0208:0635840641 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Aug 2015
- Registered office
- 3271 Scherpenheuvel-Zichem
- Size
- Micro · 8.3 FTE
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DYSS (SRL) has been based in Scherpenheuvel-Zichem since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 186,896 € and equity of €1.87m; its revenue is not published. With 8.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.7%, below the median of its sector (44.0%).
Companies similar to DYSS
Companies in the same business, of comparable size and area, outside its group.
- Torramie Activities of holding companies Evergem · balance sheet €3.79m
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- Chaflo Retail sale of pharmaceutical products Dendermonde · balance sheet €6.17m
- met Apotheken Retail sale of pharmaceutical products Bree · balance sheet €8.05m
- K & K Management Retail sale of pharmaceutical products Mol · balance sheet €2.36m
- VB Farma Retail sale of pharmaceutical products Dentergem · balance sheet €3.67m
- Cathy Bernard Management Retail sale of pharmaceutical products Soumagne · balance sheet €3.03m
- VAN Rengen - Versele Retail sale of pharmaceutical products Horebeke · balance sheet €1.92m
Frequently asked questions about DYSS
What is the revenue of DYSS?
DYSS files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DYSS?
In Belgium, the VAT number is the company number prefixed with BE: BE0635840641 for DYSS, if the company is VAT-registered. Its company number (CBE) is 0635.840.641.
Where is the registered office of DYSS?
According to the CBE register, the registered office of DYSS is in 3271 Scherpenheuvel-Zichem.
What is the equity of DYSS?
At the close of the 2025 financial year, the equity of DYSS amounts to 1,872,761 €, a solvency of 27.7% of total assets.
How many people work at DYSS?
8.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages DYSS?
The register lists 2 active mandates at DYSS. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DYSS
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →